These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 16199844)

  • 1. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
    Perlis RH; Perlis CS; Wu Y; Hwang C; Joseph M; Nierenberg AA
    Am J Psychiatry; 2005 Oct; 162(10):1957-60. PubMed ID: 16199844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Financial conflict of interest in clinical psychiatry studies: a review].
    Ulaş H; Binbay T; Alptekin K
    Turk Psikiyatri Derg; 2008; 19(4):418-26. PubMed ID: 19110984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Industry funding and author-industry affiliation in clinical trials in psychiatry.
    Montgomery JH
    Am J Psychiatry; 2006 Jun; 163(6):1110-1; author reply 1111. PubMed ID: 16741218
    [No Abstract]   [Full Text] [Related]  

  • 4. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
    Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
    Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
    JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent and impact of industry sponsorship conflicts of interest in dermatology research.
    Perlis CS; Harwood M; Perlis RH
    J Am Acad Dermatol; 2005 Jun; 52(6):967-71. PubMed ID: 15928613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.
    Bero L; Oostvogel F; Bacchetti P; Lee K
    PLoS Med; 2007 Jun; 4(6):e184. PubMed ID: 17550302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study.
    Montedori A; Bonacini MI; Casazza G; Luchetta ML; Duca P; Cozzolino F; Abraha I
    Trials; 2011 Feb; 12():58. PubMed ID: 21356072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials.
    Safer DJ
    J Nerv Ment Dis; 2002 Sep; 190(9):583-92. PubMed ID: 12357091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industry sponsorship and authorship of clinical trials over 20 years.
    Buchkowsky SS; Jewesson PJ
    Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sponsorship bias in the comparative efficacy of psychotherapy and pharmacotherapy for adult depression: meta-analysis.
    Cristea IA; Gentili C; Pietrini P; Cuijpers P
    Br J Psychiatry; 2017 Jan; 210(1):16-23. PubMed ID: 27810891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes, Interventions and Funding in Randomised Research Published in High-Impact Journals.
    Grey P; Grey A; Bolland MJ
    Trials; 2018 Oct; 19(1):592. PubMed ID: 30373636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.
    Bhandari M; Busse JW; Jackowski D; Montori VM; Schünemann H; Sprague S; Mears D; Schemitsch EH; Heels-Ansdell D; Devereaux PJ
    CMAJ; 2004 Feb; 170(4):477-80. PubMed ID: 14970094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependability of results in conference abstracts of randomized controlled trials in ophthalmology and author financial conflicts of interest as a factor associated with full publication.
    Saldanha IJ; Scherer RW; Rodriguez-Barraquer I; Jampel HD; Dickersin K
    Trials; 2016 Apr; 17(1):213. PubMed ID: 27113767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between drug company funding and outcomes of clinical psychiatric research.
    Kelly RE; Cohen LJ; Semple RJ; Bialer P; Lau A; Bodenheimer A; Neustadter E; Barenboim A; Galynker II
    Psychol Med; 2006 Nov; 36(11):1647-56. PubMed ID: 16893480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.
    Cosgrove L; Bursztajn HJ; Krimsky S; Anaya M; Walker J
    Psychother Psychosom; 2009; 78(4):228-32. PubMed ID: 19401623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs.
    Tibau A; Bedard PL; Srikanthan A; Ethier JL; Vera-Badillo FE; Templeton AJ; Ocaña A; Seruga B; Barnadas A; Amir E
    J Clin Oncol; 2015 Jan; 33(1):100-6. PubMed ID: 25385736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bias from industry trial funding? A framework, a suggested approach, and a negative result.
    Barden J; Derry S; McQuay HJ; Moore AR
    Pain; 2006 Apr; 121(3):207-218. PubMed ID: 16495012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial relationships in economic analyses of targeted therapies in oncology.
    Valachis A; Polyzos NP; Nearchou A; Lind P; Mauri D
    J Clin Oncol; 2012 Apr; 30(12):1316-20. PubMed ID: 22430267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study.
    Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD
    BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.